Emma Reeve, Chief Financial Officer at CONSTELLATION PHARMACEUTICALS INC (CNST), sold 589 shares at $36.59 ($22K) on 2020-06-08, disclosed to the SEC on 2020-06-10.
Scheduled sale ($22k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.59 | 212 | $8K | 35.1% |
| 2 | $37.67 | 144 | $5K | 24.5% |
| 3 | $38.35 | 233 | $9K | 40.4% |
| Total | $37.55 avg | 589 | $22K | 100% |
| Filing → |
| PTCT | SELL | 2025-11-25 | $795K | — | Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |